Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

安博诺 - NMPA Drug Approval Details

Approvals/NMPA/Irbesartan and Hydrochlorothiazide Tablets

Approved

化学药品

Irbesartan and Hydrochlorothiazide Tablets

SANOFI WINTHROP INDUSTRIE🇨🇳 National Medical Products Administration

Approval Date: Jan 12, 2023
Approval ID: 1z32PStPXos
Company: SANOFI WINTHROP INDUSTRIE
Type: 化学药品

Approval Details

Approval Id: 1z32PStPXos
Approval Number: 国药准字HJ20140196
Generic Name: 厄贝沙坦氢氯噻嗪片
Generic Name En: Irbesartan and Hydrochlorothiazide Tablets
Trade Name: 安博诺
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 300mg/12.5mg
Reg Date: 2023-01-12
Expired Date: 2028-01-11
Company Name: SANOFI WINTHROP INDUSTRIE
Production Company Name: SANOFI WINTHROP INDUSTRIE
Company Detail Path: /organization/sanofi-winthrop-industrie
Production Company Detail Path: /organization/sanofi-winthrop-industrie

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 12, 2023

Approval ID

1z32PStPXos

Type

化学药品

Back to NMPA Approvals